US Stocks
—
| # | Ticker | Company | Price | Chg % | Mkt Cap | P/E | EPS Growth TTM | Div Yield | Sector | Return 1Y | Revenue Growth… | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | United Therapeutics Corporation | $572.20 | -1.6% | $24.97B | 20.5 | 13.3% | — | Healthcare | 91.6% | 10.6% | ||
| 2 | Jazz Pharmaceuticals plc | $212.26 | 2% | $13.32B | -36.3 | -98.5% | — | Healthcare | 79.6% | 9.2% | ||
| 3 | Alkermes plc | $36.25 | 6.1% | $6.12B | 25.3 | -34.1% | — | Healthcare | 15.4% | -5.2% | ||
| 4 | Liquidia Corporation | $40.13 | 4.3% | $3.48B | -24.2 | 10.6% | — | Healthcare | 148.9% | 343.4% | ||
| 5 | Arcutis Biotherapeutics, Inc. | $23.42 | -0.3% | $2.89B | -180.2 | 87.6% | — | Healthcare | 52% | 91.3% | ||
| 6 | ADMA Biologics, Inc. | $10.25 | -0.6% | $2.44B | 12.7 | 210.2% | — | Healthcare | -56.8% | 27.6% | ||
| 7 | Zai Lab Limited | $20.98 | -1.1% | $2.32B | -13.1 | 91.4% | — | Healthcare | -32.2% | 15.3% | ||
| 8 | Mineralys Therapeutics, Inc. | $29.28 | -1.2% | $2.31B | -12.8 | 9.8% | — | Healthcare | 87.3% | — | ||
| 9 | Ardelyx, Inc. | $7.13 | -2.3% | $1.75B | -27.4 | -4.8% | — | Healthcare | 90.6% | 18.2% | ||
| 10 | Phathom Pharmaceuticals, Inc. | $12.60 | -2.1% | $1B | -4.2 | 59.5% | — | Healthcare | 388.2% | 150.3% | ||
| 11 | Theravance Biopharma, Inc. | $16.73 | -1.1% | $848M | -14.5 | 156.4% | — | Healthcare | 62.6% | 27.1% | ||
| 12 | Akebia Therapeutics, Inc. | $1.45 | -3.3% | $385M | -72.5 | 93.9% | — | Healthcare | -38% | 47.5% | ||
| 13 | Amarin Corporation plc | $14.50 | 1.8% | $302M | -8.1 | 62.1% | — | Healthcare | 36.8% | 0.3% | ||
| 14 | Sol-Gel Technologies Ltd. | $75.29 | -3.1% | $210M | -34.2 | 70.2% | — | Healthcare | 1603.3% | 282.9% | ||
| 15 | Milestone Pharmaceuticals Inc. | $1.88 | -0.8% | $200M | -2.5 | -13% | — | Healthcare | 41.4% | — | ||
| 16 | Jyong Biotech Ltd. Ordinary Shares | $2.07 | -1.9% | $154M | -52.1 | — | — | Healthcare | -79.5% | — | ||
| 17 | Verrica Pharmaceuticals Inc. | $7.16 | 12.6% | $123M | -4.3 | 89.1% | — | Healthcare | 60.5% | 370.2% | ||
| 18 | Tenax Therapeutics, Inc. | $12.49 | -6.2% | $74M | -10.9 | 92.9% | — | Healthcare | 122.2% | — | ||
| 19 | Unicycive Therapeutics, Inc. | $8.08 | 1.3% | $54M | -1.4 | 50.9% | 2% | Healthcare | 24.7% | — | ||
| 20 | Daré Bioscience, Inc. | $3.27 | 5.1% | $28M | -6.8 | -254.6% | — | Healthcare | 8.3% | -103% | ||
| 21 | Pelthos Therapeutics Inc. | $25.45 | 2.5% | $15M | -1.9 | -102.6% | — | Healthcare | 115.7% | — | ||
| 22 | Citius Pharmaceuticals, Inc. | $0.69 | -3.3% | $12M | -0.2 | 37.1% | — | Healthcare | -15.2% | -100% | ||
| 23 | Palatin Technologies, Inc. | $20.00 | -0.2% | $11M | -0.6 | -43% | — | Healthcare | 11023.5% | 2461% | ||
| 24 | Processa Pharmaceuticals, Inc. | $2.66 | -0.7% | $7M | -0.3 | -7480% | — | Healthcare | 980.4% | — | ||
| 25 | Cuprina Holdings (Cayman) Limited Class A Ordinary Shares | $0.27 | 1.8% | $4M | -4.7 | — | — | Healthcare | -95.1% | — | ||
| 26 | NKGen Biotech, Inc. Common Stock | $0.06 | 0% | $3M | -0.0 | 69.6% | — | Healthcare | -52.8% | — | ||
| 27 | CASI Pharmaceuticals, Inc. | $0.15 | 3.8% | $2M | -0.1 | -41.7% | 31.1% | Healthcare | -92.2% | 21.7% | ||
| 28 | OSR Holdings, Inc. | $0.52 | -10.8% | $2M | -1.0 | -4600.8% | — | Healthcare | -62.2% | — | ||
| 29 | InMed Pharmaceuticals Inc. | $0.74 | -1.1% | $2M | -0.1 | -2141.6% | — | Healthcare | -75.5% | 16960.1% | ||
| 30 | Avenue Therapeutics, Inc. | $0.53 | -18.5% | $2M | -0.6 | 123.8% | — | Healthcare | 130.3% | — | ||
| 31 | Jaguar Health, Inc. | $3.01 | -7.4% | $200586 | -0.0 | 99.3% | — | Healthcare | -99.3% | -1.5% | ||
| 32 | Lipella Pharmaceuticals Inc. | $0.04 | 65.6% | $41823 | -0.0 | 41.3% | — | Healthcare | -98.4% | -64.1% | ||
| 33 | Windtree Therapeutics, Inc. | $0.02 | -1.4% | $1141 | -0.0 | 99.1% | 100% | Healthcare | -97.9% | — |
Showing 33 stocks